Resveratrol and derivatives for the treatment of atrial fibrillation

Resveratrol is a bioactive polyphenol, found in grapes, red wine, and peanuts, and has recently garnered much media and scientific attention for its diverse beneficial health effects as a nutritional supplement or nutraceutical. Of particular interest are the well-documented cardioprotective effects...

Teljes leírás

Elmentve itt :
Bibliográfiai részletek
Szerzők: Baczkó István
Light Peter E.
Dokumentumtípus: Cikk
Megjelent: 2015
Sorozat:ANNALS OF THE NEW YORK ACADEMY OF SCIENCES 1348 No. 1
doi:10.1111/nyas.12843

mtmt:2942330
Online Access:http://publicatio.bibl.u-szeged.hu/16227
LEADER 02101nab a2200217 i 4500
001 publ16227
005 20190726133339.0
008 190726s2015 hu o 0|| zxx d
022 |a 0077-8923 
024 7 |a 10.1111/nyas.12843  |2 doi 
024 7 |a 2942330  |2 mtmt 
040 |a SZTE Publicatio Repozitórium  |b hun 
041 |a zxx 
100 1 |a Baczkó István 
245 1 0 |a Resveratrol and derivatives for the treatment of atrial fibrillation  |h [elektronikus dokumentum] /  |c  Baczkó István 
260 |c 2015 
300 |a 68-74 
490 0 |a ANNALS OF THE NEW YORK ACADEMY OF SCIENCES  |v 1348 No. 1 
520 3 |a Resveratrol is a bioactive polyphenol, found in grapes, red wine, and peanuts, and has recently garnered much media and scientific attention for its diverse beneficial health effects as a nutritional supplement or nutraceutical. Of particular interest are the well-documented cardioprotective effects of resveratrol that are mediated by diverse mechanisms, including its antioxidant and vascular effects. However, it is now becoming clear that resveratrol may also exhibit direct effects on cardiac function and rhythm through modulation of signaling pathways that regulate cardiac remodeling and ion channel activity that controls cardiac excitability. Resveratrol may therefore possess antiarrhythmic properties that contribute to the cardiovascular benefits of resveratrol. Atrial fibrillation (AF) is the most common cardiac arrhythmia, although current therapies are suboptimal. Our laboratory has been studying resveratrol's effects on cardiac ion channels and remodeling pathways, and we initiated a drug development program aimed at generating novel resveratrol derivatives with improved efficacy against AF when compared to currently available therapeutics. This review therefore focuses on the effects of resveratrol and new derivatives on a variety of cardiac ion channels and molecular pathways that contribute to the development and maintenance of atrial fibrillation. 
700 0 1 |a Light Peter E.  |e aut 
856 4 0 |u http://publicatio.bibl.u-szeged.hu/16227/1/Baczko.pdf  |z Dokumentum-elérés